Biomarkers And Neurological Outcome in Neonates 2
BANON2
Validation of Biomarkers of Adverse Neurologic Outcome in Newborns at Risk for Perinatal Brain Injury - Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test
1 other identifier
observational
500
2 countries
13
Brief Summary
Follow-up of participants of BANON1 study at age of at least 2 years. BANON1 (ClinicalTrials.gov ID: NCT03357250): Validation of biomarkers based on 24 months neuro-developmental outcome data in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies and a preliminary human study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2019
Typical duration for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2019
CompletedFirst Submitted
Initial submission to the registry
January 13, 2021
CompletedFirst Posted
Study publicly available on registry
January 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJanuary 20, 2021
January 1, 2021
2.3 years
January 13, 2021
January 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
participants with normal neuro-developmental status
all infants with normal neuro-developmental status
up to 42 month age
participants with potentially abnormal neuro-developmental status
All infants who do not fulfill outcomes 1, 3 or 4
up to 42 month age
participants with abnormal neuro-developmental status - HIE
Presence of adverse 2 years neuro-developmental outcome likely attributable to perinatal hypoxic-ischemic brain injury
up to 42 month age
participants with abnormal neuro-developmental status - non-HIE
Presence of adverse 2 years neuro-developmental outcome not attributable to perinatal hypoxic-ischemic brain injury
up to 42 month age
Eligibility Criteria
Children, who had been enrolled in the BANON study immediately after birth because they had been suspected to be at risk for perinatal brain injury (hypoxic-ischemic encephalopathy, HIE) and/or evaluated for hypothermia therapy.
You may qualify if:
- Infants previously enrolled in BANON study
You may not qualify if:
- Missing valid written informed parental consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- InfanDx AGlead
- University Hospital Tuebingencollaborator
Study Sites (13)
Städtisches Krankenhaus Aschaffenburg
Aschaffenburg, 63739, Germany
Universitätsklinikum Carl Gustav Carus, Neonatologie
Dresden, 01307, Germany
Uniklinik Essen
Essen, 45147, Germany
Marienkrankenhaus
Hamburg, 22149, Germany
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
Städtisches Klinikum Karlsruhe, Klinik für Kinder- und Jugendmedizin
Karlsruhe, 76133, Germany
Klinik für Kinder- und Jugendmedizin, Klinikum Dritter Orden,
München, 80638, Germany
Universitäts Kinderkrankenhaus und Perinatal Zentrum
München, 81377, Germany
Kinderklinik Dritter Orden
Passau, 94032, Germany
Klinik St. Hedwig
Regensburg, 93049, Germany
Universitätsklinikum Tübingen, Universiätsklinik für Kinder- u. Jugendmedizin
Tübingen, 72076, Germany
Cukurova University Hospital
Adana, 01330, Turkey (Türkiye)
University of Firat, Department of Pediatrics
Elâzığ, 23040, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ron Meyer
InfanDx AG
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2021
First Posted
January 19, 2021
Study Start
February 5, 2019
Primary Completion
June 1, 2021
Study Completion
December 1, 2021
Last Updated
January 20, 2021
Record last verified: 2021-01